2007 IW US 500 Company Profile

Gilead Sciences Inc.
Pharmaceuticals
Foster City, California
2007 IW US 500 Rank:
Current Rank : 258
Prior Rank : 333
Executive 1 : James M. Denny, Chairman
Executive 2 : John C. Martin, President; Chief Executive Officer
258 of 500
2006 Revenue (US$ Millions)$3,026
Revenue Growth (%)49.19%
Net Income (US$ Millions)($1,189)
Earnings Per Share (US$)($2.59)
Total Equity (US$ Millions)$1,815
Profit Growth (%)(246.2%)
Profit Margin (%)(39.32%)
Return On Equity (%)(39.3%)
Debt To Equity Ratio (%)0.77%
Market Capitalization (US$ Millions)NA
THE LATEST
More
IW US 500 Stock Index

Subscribe to IW Newsletters
IW Marketplace - Buy a Link Now